Literature DB >> 20550926

Whole-genome sequencing breaks the cost barrier.

Laura Bonetta.   

Abstract

The ever-decreasing cost of sequencing is ushering in a new era in genomic medicine. Laura Bonetta reports on new studies that provide a glimpse of the opportunities ahead. Copyright 2010 Elsevier Inc. All rights reserved.

Mesh:

Year:  2010        PMID: 20550926     DOI: 10.1016/j.cell.2010.05.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  24 in total

1.  Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis.

Authors:  Benjamin J Grady; Marylyn D Ritchie
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-03-01

2.  Personal genomic information management and personalized medicine: challenges, current solutions, and roles of HIM professionals.

Authors:  Amal Alzu'bi; Leming Zhou; Valerie Watzlaf
Journal:  Perspect Health Inf Manag       Date:  2014-04-01

3.  Implementing the VMC Specification to Reduce Ambiguity in Genomic Variant Representation.

Authors:  Michael Watkins; Shawn Rynearson; Alex Henrie; Karen Eilbeck
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

4.  Education of a child neurologist: developmental neuroscience relevant to child neurology.

Authors:  Michael V Johnston
Journal:  Semin Pediatr Neurol       Date:  2011-06       Impact factor: 1.636

Review 5.  Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations.

Authors:  Sudhir Kumar; Joel T Dudley; Alan Filipski; Li Liu
Journal:  Trends Genet       Date:  2011-07-20       Impact factor: 11.639

6.  Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.

Authors:  Katherine M James; Clayton T Cowl; Jon C Tilburt; Pamela S Sinicrope; Marguerite E Robinson; Katrin R Frimannsdottir; Kristina Tiedje; Barbara A Koenig
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

7.  Controlled translocation of individual DNA molecules through protein nanopores with engineered molecular brakes.

Authors:  Marcela Rincon-Restrepo; Ellina Mikhailova; Hagan Bayley; Giovanni Maglia
Journal:  Nano Lett       Date:  2011-01-11       Impact factor: 11.189

8.  Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Authors:  Julia R Trosman; Christine B Weldon; R Kate Kelley; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

9.  Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.

Authors:  Shanique K E Edwards; Yeming Han; Yingying Liu; Benjamin Z Kreider; Yan Liu; Sukhdeep Grewal; Anand Desai; Jacqueline Baron; Carissa R Moore; Chang Luo; Ping Xie
Journal:  Leuk Res       Date:  2015-12-19       Impact factor: 3.156

Review 10.  Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.

Authors:  Paul S Knoepfler
Journal:  Regen Med       Date:  2012-07-26       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.